Apyx Medical Corporation (APYX)

NMS – Real Time Price. Currency in USD

4.09

+0.17 (4.34%)

At close: May 12, 2026, 4:00 PM EDT

4.15

+0.06 (1.47%)

After-hours: May 12, 2026, 6:20 PM EDT

11.05.2026

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON

07.05.2026

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

07.05.2026

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx Medical (APYX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.1 per share a year ago.

07.05.2026

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

CLEARWATER, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its first quarter ended March 31, 2026.

04.05.2026

Weight-loss revolution sparks new appetite for aesthetics firms

Aesthetic firms are betting that a growing pool of patients experiencing loose skin and facial volume loss from GLP-1 obesity drugs will fuel a new wave of demand, as the sector heads into first-quarter earnings this week.

23.04.2026

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

CLEARWATER, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that its financial results for the first quarter of fiscal year 2026 will be released before markets open on Thursday, May 7th.

01.04.2026

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Renuvion continues to lead in minimally invasive body contouring as the trusted solution for loose skin. CLEARWATER, Fla.

Videos

No Data

There is no data to display

Press releases

11.05.2026

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

07.05.2026

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

01.04.2026

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Renuvion continues to lead in minimally invasive body contouring as the trusted solution for loose skin. CLEARWATER, Fla.

10.03.2026

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

CLEARWATER, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its fourth quarter and full year ended December 31, 2025.

Apyx Medical Corporation (APYX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Apyx Medical Corporation (APYX)

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Weight-loss revolution sparks new appetite for aesthetics firms

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Videos

No Data

Press releases

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Weight-loss revolution sparks new appetite for aesthetics firms

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Videos

No Data

Press releases

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

Search stocks

Apyx Medical Corporation (APYX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Apyx Medical Corporation (APYX)

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Weight-loss revolution sparks new appetite for aesthetics firms

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Videos

No Data

Press releases

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Weight-loss revolution sparks new appetite for aesthetics firms

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Videos

No Data

Press releases

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results